Coenzyme Q10
- Generic Name
- Coenzyme Q10
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C59H90O4
- CAS Number
- 303-98-0
- Unique Ingredient Identifier
- EJ27X76M46
- Background
Ubidecarenone, also called coenzyme Q10, is a 1,4-benzoquinone. From its name (Q10), the Q refers to the constitutive quinone group, and 10 is related to the number of isoprenyl subunits in its tail. It is a powerful antioxidant, a lipid-soluble and essential cofactor in mitochondrial oxidative phosphorylation. The ubidecarenone is the coenzyme destined for ...
- Indication
The diet supplements containing ubidecarenone are indicated, as stated in the product label, to assist individuals with cardiovascular complaints including congestive heart failure and systolic hypertension. In the product, ubidecarenone is used to increase the cardiac input as well as for the prevention of several other diseases like Parkinson, fibromyalgia...
- Associated Conditions
- Migraine
- Associated Therapies
- -
The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Target Recruit Count
- 264
- Registration Number
- NCT06743802
- Locations
- 🇨🇳
Guangyou Duan, Chongqing, Chongqing, China
Effect Supplementation of COenzyme Q10 in Acute STEMI Underwent PPCI
- Conditions
- Interventions
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Universitas Diponegoro
- Target Recruit Count
- 46
- Registration Number
- NCT06661018
- Locations
- 🇮🇩
Dr. Kariadi Central General Hospital, Semarang, Central Java, Indonesia
Reducing Fatigue With CoQ10 Supplementation in Patients With Crohn's Disease Study
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 60
- Registration Number
- NCT06419335
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)
- Conditions
- Interventions
- First Posted Date
- 2023-10-18
- Last Posted Date
- 2024-05-02
- Lead Sponsor
- Shi Yun
- Target Recruit Count
- 76
- Registration Number
- NCT06089395
- Locations
- 🇨🇳
Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing, Beijing, China
🇨🇳Chaoyang Hospital Affiliated to Capital Medical University, Beijing, China
Coenzyme Q10 and Dentoalveolar Cyst
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Fayoum University
- Target Recruit Count
- 20
- Registration Number
- NCT05873673
Coenzyme Q10 as Treatment for Long Term COVID-19
- First Posted Date
- 2021-07-13
- Last Posted Date
- 2022-05-06
- Lead Sponsor
- Aarhus University Hospital
- Target Recruit Count
- 121
- Registration Number
- NCT04960215
- Locations
- 🇩🇰
Department of Infectious Diseases, Aarhus, Aarhus N, Denmark
Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)
- Conditions
- Interventions
- First Posted Date
- 2020-06-23
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Nanjing Medical University
- Target Recruit Count
- 500
- Registration Number
- NCT04444349
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
🇨🇳Beijing Anzhen Hospital, Beijing, Beijing, China
🇨🇳The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
Coenzyme q 10 and Fertility Outcome in Women With Clomiphene Resistant PCOS
- First Posted Date
- 2020-03-10
- Last Posted Date
- 2020-11-25
- Lead Sponsor
- Karachi Medical and Dental College
- Target Recruit Count
- 149
- Registration Number
- NCT04302532
- Locations
- 🇵🇰
Aziz medical center, Karachi, Sindh, Pakistan
Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
- Conditions
- Interventions
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2019-07-18
- Lead Sponsor
- Zagazig University
- Target Recruit Count
- 300
- Registration Number
- NCT03961087
- Locations
- 🇪🇬
Amr Shaaban Hanafy, Zagazig, Alsharkia, Egypt
Anti-oxidant Therapy and Postoperative Cardiac Events (ACE) Trial, Preoperative Intervention in Vascular Surgery
- First Posted Date
- 2019-05-20
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- Minneapolis Veterans Affairs Medical Center
- Target Recruit Count
- 341
- Registration Number
- NCT03956017
- Locations
- 🇺🇸
Va Medical Center, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.